Corrections: Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data (The Lancet (2014) 14(8) (742–750)(S1473309914707807)(10.1016/S1473-3099(14)70780-7));Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data

The Lancet Infectious Diseases

Volumn 14, Issue 8, 2014, Pages 742-750

  Van Boeckel, Thomas P ^a   Gandra, Sumanth ^b   Ashok, Ashvin ^b   Caudron, Quentin ^a   Grenfell, Bryan T ^a,e   Levin, Simon A ^a,d   Laxminarayan, Ramanan ^a,b,c  

^a PRINCETON UNIVERSITY   (United States)

^b Center for Disease Dynamics Economics and Policy   (United States)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^d Beijer Institute of Ecological Economics   (Sweden)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBACEPHEM DERIVATIVE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; GLYCOPEPTIDE; MACROLIDE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN PLUS STREPTOMYCIN; POLYMYXIN; QUINOLONE DERIVATIVE; RIFAMYCIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ARTICLE; DRUG MARKETING; DRUG USE; HUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; COMMERCE; DRUG UTILIZATION; HEALTH POLICY; HUMANS; WORLD HEALTH;

EID: 84904761947     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30241-4     Document Type: Erratum

References (60)

1. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013, 13:1057-1098.
2. Davies J, Davies D Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010, 74:417-433.
3. Levy SB, Marshall B Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004, 10:S122-S129.
4. Antimicrobial resistance factsheet WHO, (accessed Dec 19, 2013). http://www.who.int/mediacentre/factsheets/fs194/en/.
5. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368:874-885.
6. Nordmann P, Naas T, Poirel L Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
7. Laxminarayan R, Heymann DL Challenges of drug resistance in the developing world. BMJ 2012, 344:e1567.
8. Goossens H, Ferech M, Vander Stichele R, Elseviers M Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587. for the ESAC Project Group.
9. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013, 62:34-42.
10. Shorr AF Epidemiology of staphylococcal resistance. Clin Infect Dis 2007, 45:S171-S176.
11. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
12. Resistance Map The Center for Disease Dynamics, Economics, and Policy, (accessed July 2, 2014). http://www.cddep.org/map.
13. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005, 5:481-493.
14. Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis 2005, 5:568-580.
15. Ferech M, Coenen S, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006, 58:401-407.
16. Col NF, O'Connor RW Estimating worldwide current antibiotic usage: report of Task Force 1. Rev Infect Dis 1987, 9(suppl 3):S232-S243.
17. Population estimates and projections World Bank Data Catalog, (accessed June 21, 2014). http://data.worldbank.org/data-catalog/population-projection-tables.
18. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009, 373:240-249.
19. Radyowijati A, Haak H Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003, 57:733-744.
20. Marmot M, Friel S, Bell R, Houweling TA, Taylor S Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 2008, 372:1661-1669. Commission on Social Determinants of Health.
21. Team APW Antimicrobial stewardship: what's it all about? Australian Prescriber (accessed April 14, 2014). http://www.australianprescriber.com/magazine/36/4/116/20.
22. Antimicrobial stewardship in Australian Hospitals 2011 (accessed June 21, 2014). http://www.sahealth.sa.gov.au/wps/wcm/connect/a8a83d004009152a8bb1bb4826472d56/national-antimicrobial-annual-report-2012_2013-phcs-ics-20131128.pdf?MOD=AJPERES&CACHEID=a8a83d004009152a8bb1bb4826472d56.
23. Huttner B, Goossens H, Verheij T, Harbarth S Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010, 10:17-31. for the CHAMP consortium.
24. National Antimicrobial Utilisation Surveillance Program (accessed June 21, 2014). http://www.sahealth.sa.gov.au/wps/wcm/connect/a8a83d004009152a8bb1bb4826472d56/national-antimicrobial-annual-report-2012_2013-phcs-ics-20131128.pdf?MOD=AJPERES&CACHEID=a8a83d004009152a8bb1bb4826472d56.
25. Thomas MG, Smith AJ, Tilyard M Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand. N Z Med J 2014, 127:72-84.
26. Ticehurst R, Thomas M Antimicrobial consumption at Auckland City Hospital: 2006-2009. N Z Med J 2011, 124:1332.
27. Goossens H, Ferech M, Coenen S, Stephens P Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007, 44:1091-1095.
28. Dhillon RH-P, Clark J ESBLs: a clear and present danger?. Crit Care Res Pract 2012, 2012:625170.
29. Pitout JD, Laupland KB Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
30. Gupta N, Limbago BM, Patel JB, Kallen AJ Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011, 53:60-67.
31. Higgins PG, Dammhayn C, Hackel M, Seifert H Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
32. Edelstein MV, Skleenova EN, Shevchenko OV, et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis 2013, 13:867-876.
33. Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson NF Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis 1984, 149:16-22.
34. DeMaria A, Treadwell TL, Saunders CA, Porat R, McCabe WR Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by Gram-negative bacilli. Antimicrob Agents Chemother 1989, 33:1137-1143.
35. Fahad BM, Matin A, Shill MC, Asish KD Antibiotic usage at a primary health care unit in Bangladesh. Australas Med J 2010, 3:414-421.
36. Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, South India. J Antimicrob Chemother 2013, 68:229-236.
37. Hou F-Q, Wang Y, LI J, Wang G-Q, Liu Y Management of acute diarrhea in adults in China: a cross-sectional survey. BMC Public Health 2013, 13:41.
38. Kotwani A, Chaudhury RR, Holloway K Antibiotic-prescribing practices of primary care prescribers for acute diarrhea in New Delhi, India. Value Health 2012, 15:S116-S119.
39. Supcharassaeng S, Suankratay C Antibiotic prescription for adults with acute diarrhea at King Chulalongkorn Memorial Hospital, Thailand. J Med Assoc Thail 2011, 94:545-550.
40. Diniz-Santos DR, Silva LR, Silva N Antibiotics for the empirical treatment of acute infectious diarrhea in children. Braz J Infect Dis 2006, 10:217-227.
41. Bhaskar ME, Moorthy S, Kumar NS, Arthur P Dengue haemorrhagic fever among adults-an observational study in Chennai, south India. Indian J Med Res 2010, 132:738-740.
42. Shoaib Khan HM, Qamar-uz-zaman, Ali Khan B, Arif M, Raza A, Anamul-Haq Retrospective analysis of 68 cases of dengue fever. Pak J Med Res 2012, 51:18-20.
43. Phuong HL, de Vries PJ, Nagelkerke N, et al. Acute undifferentiated fever in Binh Thuan province, Vietnam: imprecise clinical diagnosis and irrational pharmaco-therapy. Trop Med Int Health 2006, 11:869-879.
44. Kotwani A, Holloway K Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis 2011, 11:99.
45. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
46. Hati AK Dengue serosurveillance in Kolkata, facing an epidemic in West Bengal, India. J Vector Borne Dis 2009, 46:197-204.
47. Pramanik MK, Aditya G, Raut SK Seasonal prevalence of Aedes aegypti immatures in Kolkata, India. Southeast Asian J Trop Med Public Health 2007, 38:442-447.
48. Sharma RS, Kaul SM, Sokhay J Seasonal fluctuations of dengue fever vector, Aedes aegypti (Diptera: Culicidae) in Delhi, India. Southeast Asian J Trop Med Public Health 2005, 36:186-190.
49. Armstrong GL, Conn LA, Pinner RW Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281:61-66.
50. Walsh TR, Weeks J, Livermore DM, Toleman MA Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011, 11:355-362.
51. Dong H, Bogg L, Rehnberg C, Diwan V Health financing policies. Providers' opinions and prescribing behavior in rural China. Int J Technol Assess Health Care 1999, 15:686-698.
52. qxc16070. Proceedings of the 2nd National Workshop on Rational Use. (accessed June 25, 2014). http://www.haiasiapacific.org/wp-content/uploads/2014/03/Antibiotics-Rational-Use-report-China-2005.pdf.
53. Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011, 11:692-701.
54. Mölstad S, Erntell M, Hanberger H, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 2008, 8:125-132.
55. Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006, 62:373-379.
56. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
57. Children: reducing mortality factsheet WHO, (accessed Dec 19, 2013). http://www.who.int/mediacentre/factsheets/fs178/en/.
58. MacKenzie FM, Gould IM Quantitative measurement of antibiotic use. Antibiotic policies: theory and practice 2005, 105-118. Springer, New York. I.M. Gould, J.W.M. van der Meer (Eds.).
59. Disposal of unwanted medicines Pharmaceutical Services Negotiating Committee, (accessed April 14, 2014). http://psnc.org.uk/services-commissioning/essential-services/disposal-of-unwanted-medicines/.
60. Leeb M Antibiotics: a shot in the arm. Nature 2004, 431:892-893.